Early Access Programs in France (ATU)

June 21, 2021
  • Early Access to market

Our experts at BlueReg are covering the Early Access Programs specific to France (ATU), and how to take advantage of it.

The different subjects discussed in the webinar are :

  • Why Early Access (ATU) for new innovative drugs in France is attractive and complex at the same time?
  • Why having a third party to run your Early Access in France is highly recommended?
  • Get ready for the new Early Access regulation(Replacing ATU)
  • Q&A session with the BlueReg experts



Access the Full Webinar and the slide deck

    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more

    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to: GDPR data request

    GDPR data request

    Thank you! You can watch the webinar now.

    Download your document